Rehydralyte Clinical ORS from Japan
Rehydralyte clinical oral rehydration solution powder for institutional use, classified 3006.93.20. USMCA 9823.10.12 eligibility under note 10(b)(2) for Canada/Mexico origin. Hospital-grade dehydration therapy.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Facility registration with FDA required,USMCA docs must reference clinical ORS status,Cold chain validation documentation